Mankind Pharma Limited (MANKIND)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 2,052.67 2,578.62 2,708.10 2,606.96 2,441.10 2,893.42 3,076.51 3,230.00 3,079.37 3,570.35 3,697.16 3,567.20
YOY Revenue Growth % - - - - 18.92% 12.21% 13.6% 23.9% 26.15% 23.4% 20.17% 10.44%
Other Income 47.51 58.62 59.98 70.13 92.13 100.60 109.43 77.32 251.33 79.88 91.87 72.75
Total Income 2,100.18 2,637.24 2,768.08 2,677.09 2,533.23 2,994.02 3,185.94 3,307.32 3,330.70 3,650.23 3,789.03 3,639.95
Total Expenses + 1,424.40 1,590.53 1,674.34 1,629.61 1,549.05 1,872.11 1,813.57 2,001.09 2,817.59 3,112.91 3,167.33 3,027.57
Cost of Materials Consumed 462.10 486.69 473.74 456.74 436.34 472.98 461.99 536.11 554.25 585.68 594.36 553.04
Employee Benefit Expense 495.88 552.91 571.96 568.35 581.51 633.78 646.43 709.71 715.80 783.41 825.18 823.71
Other Expenses 466.42 550.93 628.63 604.51 531.20 765.35 705.15 755.27 805.00 886.58 888.48 846.07
Operating Profit 628.26 988.09 1,033.76 977.35 892.05 1,021.31 1,262.94 1,228.91 261.78 457.44 529.83 539.63
OPM % 30.6% 38.3% 38.2% 37.5% 36.5% 35.3% 41.1% 38% 8.5% 12.8% 14.3% 15.1%
Profit Before Tax + 374.51 619.74 637.52 557.73 569.16 663.71 846.75 493.89 513.11 537.32 621.70 505.79
Tax Expense 80.82 125.55 126.34 97.91 92.57 120.64 187.87 109.37 88.46 92.70 101.52 91.91
Tax % 21.6% 20.3% 19.8% 17.6% 16.3% 18.2% 22.2% 22.1% 17.2% 17.3% 16.3% 18.2%
Profit After Tax 293.70 494.19 511.18 459.81 476.59 543.07 658.88 384.52 424.65 444.62 520.18 413.88
EPS (Basic) 7.13 12.15 12.51 11.33 11.76 13.39 16.31 9.45 10.19 10.62 12.39 9.90

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 12,207.44 10,334.77 8,749.43
YOY Revenue Growth % 18.12% 18.12% -
Other Income 536.79 280.86 128.57
Total Income 12,744.23 10,615.63 8,878.00
Total Expenses + 10,240.14 6,443.52 5,748.82
Cost of Materials Consumed 2,016.35 1,853.52 1,813.66
Employee Benefit Expense 2,692.37 2,274.73 1,918.47
Other Expenses 3,008.10 2,315.28 2,016.68
Operating Profit 1,967.30 3,891.25 3,000.62
OPM % 16.1% 37.7% 34.3%
Profit Before Exceptional 2,504.09 2,384.14 1,658.81
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 2,504.09 2,384.14 1,658.81
Tax Expense 492.97 442.37 349.14
Tax % 19.7% 18.6% 21%
Profit After Tax 2,011.12 1,941.77 1,309.68
EPS (Basic) 49.28 47.75 32.00

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 20,581.77 5,313.04 5,285.06
Property, Plant & Equipment 2,907.82 2,931.59 2,523.80
Capital Work in Progress 306.13 207.09 493.19
Non-Current Investments 160.19 309.81 270.95
Goodwill 6,492.63 20.02 20.02
Other Intangible Assets 9,604.03 1,588.34 1,701.46
Current Assets + 7,175.06 6,647.51 4,427.07
Inventories 2,093.71 1,553.46 1,498.46
Trade Receivables 1,538.34 848.28 576.42
Cash and Cash Equivalents 407.36 382.01 304.82
Current Investments 1,000.00 1,000.00 1,000.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 41.26 40.06 40.06
Other Equity 14,291.13 9,323.03 7,395.16
Non-Current Liabilities 7,527.79 267.74 229.02
Current Liabilities 5,663.56 2,119.73 1,863.14
Total Liabilities 13,191.35 2,387.47 2,092.16

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 2,413.38 2,152.45 1,813.30
Cash from Investing Activities -12,682.95 -2,081.69 -1,054.13
Cash from Financing Activities 10,290.13 5.27 -739.73
Net Increase/Decrease in Cash 21.87 77.19 21.76